Altimmune Free Cash Flow Per Share vs Cash Ratio Analysis

ALT Stock  USD 7.21  0.11  1.50%   
Altimmune financial indicator trend analysis is way more than just evaluating Altimmune prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Altimmune is a good investment. Please check the relationship between Altimmune Free Cash Flow Per Share and its Cash Ratio accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Altimmune. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
For more information on how to buy Altimmune Stock please use our How to Invest in Altimmune guide.

Free Cash Flow Per Share vs Cash Ratio

Free Cash Flow Per Share vs Cash Ratio Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Altimmune Free Cash Flow Per Share account and Cash Ratio. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between Altimmune's Free Cash Flow Per Share and Cash Ratio is -0.32. Overlapping area represents the amount of variation of Free Cash Flow Per Share that can explain the historical movement of Cash Ratio in the same time period over historical financial statements of Altimmune, assuming nothing else is changed. The correlation between historical values of Altimmune's Free Cash Flow Per Share and Cash Ratio is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Free Cash Flow Per Share of Altimmune are associated (or correlated) with its Cash Ratio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cash Ratio has no effect on the direction of Free Cash Flow Per Share i.e., Altimmune's Free Cash Flow Per Share and Cash Ratio go up and down completely randomly.

Correlation Coefficient

-0.32
Relationship DirectionNegative 
Relationship StrengthInsignificant

Free Cash Flow Per Share

The amount of cash a company generates after accounting for capital expenditures, divided by the number of outstanding shares. It represents the cash available for dividends, share buybacks, or debt repayment per share.

Cash Ratio

Most indicators from Altimmune's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Altimmune current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Altimmune. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
For more information on how to buy Altimmune Stock please use our How to Invest in Altimmune guide.At this time, Altimmune's Tax Provision is comparatively stable compared to the past year. Sales General And Administrative To Revenue is likely to gain to 51.41 in 2025, despite the fact that Enterprise Value Over EBITDA is likely to grow to (5.77).
 2022 2023 2024 2025 (projected)
Research Development70.5M65.8M75.7M79.5M
Depreciation And Amortization500K477K429.3K435.7K

Altimmune fundamental ratios Correlations

0.360.380.87-0.92-0.50.490.950.980.080.820.30.720.40.990.30.13-0.140.01-0.27-0.280.03-0.070.380.150.84
0.361.0-0.14-0.420.3-0.020.380.40.39-0.12-0.07-0.231.00.370.3-0.11-0.1-0.290.24-0.11-0.21-0.180.93-0.290.33
0.381.0-0.12-0.460.270.020.420.420.41-0.09-0.03-0.21.00.390.31-0.06-0.11-0.310.25-0.13-0.22-0.180.94-0.290.33
0.87-0.14-0.12-0.75-0.690.520.80.83-0.120.930.340.88-0.10.860.160.18-0.080.17-0.43-0.220.160.0-0.090.30.73
-0.92-0.42-0.46-0.750.5-0.52-0.98-0.94-0.24-0.73-0.53-0.63-0.47-0.92-0.41-0.40.260.250.160.390.130.13-0.52-0.03-0.64
-0.50.30.27-0.690.5-0.71-0.57-0.57-0.28-0.85-0.12-0.930.26-0.53-0.57-0.090.430.290.060.560.320.370.30.08-0.4
0.49-0.020.020.52-0.52-0.710.520.530.260.640.140.640.020.50.450.15-0.28-0.220.15-0.35-0.23-0.190.11-0.10.38
0.950.380.420.8-0.98-0.570.520.960.240.80.460.720.430.950.420.34-0.26-0.23-0.17-0.4-0.13-0.180.450.020.68
0.980.40.420.83-0.94-0.570.530.960.210.820.270.740.440.990.420.12-0.26-0.15-0.18-0.41-0.11-0.190.40.060.84
0.080.390.41-0.12-0.24-0.280.260.240.21-0.01-0.010.120.40.130.880.06-0.42-0.650.51-0.45-0.61-0.610.31-0.370.0
0.82-0.12-0.090.93-0.73-0.850.640.80.82-0.010.240.97-0.070.820.330.13-0.21-0.01-0.32-0.37-0.01-0.17-0.090.050.66
0.3-0.07-0.030.34-0.53-0.120.140.460.27-0.010.240.18-0.030.28-0.080.96-0.07-0.18-0.14-0.080.050.190.210.16-0.17
0.72-0.23-0.20.88-0.63-0.930.640.720.740.120.970.18-0.190.730.430.09-0.29-0.1-0.23-0.45-0.12-0.27-0.240.060.59
0.41.01.0-0.1-0.470.260.020.430.440.4-0.07-0.03-0.190.410.31-0.08-0.13-0.290.24-0.14-0.24-0.150.94-0.260.35
0.990.370.390.86-0.92-0.530.50.950.990.130.820.280.730.410.360.12-0.11-0.02-0.23-0.260.04-0.170.380.10.84
0.30.30.310.16-0.41-0.570.450.420.420.880.33-0.080.430.310.36-0.03-0.41-0.550.35-0.49-0.55-0.650.19-0.340.22
0.13-0.11-0.060.18-0.4-0.090.150.340.120.060.130.960.09-0.080.12-0.03-0.04-0.230.03-0.030.030.090.180.09-0.36
-0.14-0.1-0.11-0.080.260.43-0.28-0.26-0.26-0.42-0.21-0.07-0.29-0.13-0.11-0.41-0.040.7-0.230.970.93-0.01-0.040.04-0.15
0.01-0.29-0.310.170.250.29-0.22-0.23-0.15-0.65-0.01-0.18-0.1-0.29-0.02-0.55-0.230.7-0.370.740.740.48-0.270.510.08
-0.270.240.25-0.430.160.060.15-0.17-0.180.51-0.32-0.14-0.230.24-0.230.350.03-0.23-0.37-0.11-0.37-0.440.16-0.01-0.26
-0.28-0.11-0.13-0.220.390.56-0.35-0.4-0.41-0.45-0.37-0.08-0.45-0.14-0.26-0.49-0.030.970.74-0.110.880.11-0.050.16-0.28
0.03-0.21-0.220.160.130.32-0.23-0.13-0.11-0.61-0.010.05-0.12-0.240.04-0.550.030.930.74-0.370.880.08-0.140.180.03
-0.07-0.18-0.180.00.130.37-0.19-0.18-0.19-0.61-0.170.19-0.27-0.15-0.17-0.650.09-0.010.48-0.440.110.08-0.020.48-0.11
0.380.930.94-0.09-0.520.30.110.450.40.31-0.090.21-0.240.940.380.190.18-0.04-0.270.16-0.05-0.14-0.02-0.290.22
0.15-0.29-0.290.3-0.030.08-0.10.020.06-0.370.050.160.06-0.260.1-0.340.090.040.51-0.010.160.180.48-0.290.13
0.840.330.330.73-0.64-0.40.380.680.840.00.66-0.170.590.350.840.22-0.36-0.150.08-0.26-0.280.03-0.110.220.13
Click cells to compare fundamentals

Altimmune Account Relationship Matchups

Altimmune fundamental ratios Accounts

202020212022202320242025 (projected)
Total Assets245.1M218.9M206.9M210.6M242.2M254.3M
Other Current Liab11.0M6.1M10.6M9.6M11.0M17.0M
Total Current Liabilities12.0M18.3M17.1M12.1M14.0M21.2M
Total Stockholder Equity225.9M199.1M185.3M194.1M223.2M234.4M
Net Debt(114.1M)(188.8M)(110.0M)(134.4M)(121.0M)(115.0M)
Retained Earnings(186.4M)(293.2M)(377.9M)(466.3M)(419.7M)(398.7M)
Accounts Payable612.3K2.0M4.8M2.1M2.4M1.5M
Cash115.9M190.3M111.1M135.1M155.4M163.2M
Cash And Short Term Investments215.9M190.3M184.9M197.8M227.5M238.9M
Common Stock Total Equity876.01.5K3.7K4.1K4.7K3.9K
Common Stock Shares Outstanding25.6M41.3M46.9M53.2M61.2M64.3M
Liabilities And Stockholders Equity245.1M218.9M206.9M210.6M242.2M254.3M
Other Current Assets2.0B13.4B5.4M7.0M8.0M7.6M
Other Stockholder Equity417.3M497.3M568.4M665.4M765.2M803.5M
Total Liab19.2M19.7M21.6M16.5M19.0M27.3M
Total Current Assets230.3M204.1M192.8M209.6M241.1M253.1M
Common Stock3.7K4.1K5K7K8.1K4.2K
Other Assets977.2K73.8K19K1.00.90.86
Non Current Liabilities Total7.2M1.5M4.6M4.4M4.0M4.7M
Short Term Debt356.7K411.5K452K496K446.4K424.1K
Short Long Term Debt Total2.2M1.9M1.1M671K603.9K573.7K
Property Plant And Equipment Net2.0M1.4M1.1M1.0M912.6K1.5M
Non Current Assets Total14.9M14.7M14.1M1.0M1.2M1.1M
Non Currrent Assets Other73.4K872.0K615K100.0K90.0K85.5K
Net Receivables12.4M5.8M2.5M4.9M4.4M5.0M
Property Plant And Equipment Gross2.0M1.4M2.6M2.6M2.4M1.6M
Intangible Assets12.7M12.8M12.4M12.4M14.3M11.8M
Net Tangible Assets32.8M213.1M186.7M172.9M198.8M208.7M
Long Term Debt1.9M1.9M1.8M1.5M1.7M1.5M
Retained Earnings Total Equity(116.9M)(137.4M)(186.4M)(293.2M)(337.1M)(354.0M)
Capital Surpluse170.2M187.9M417.3M497.3M571.9M600.5M
Property Plant Equipment1.1M1.1M1.4M1.7M1.9M2.0M
Long Term Debt Total1.9M1.9M1.8M1.5M1.7M2.0M
Non Current Liabilities Other5.4M1.5M3.9M4.2M4.9M5.1M
Other Liab3.1M7.2M330.5K3.9M4.5M3.3M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Altimmune Stock Analysis

When running Altimmune's price analysis, check to measure Altimmune's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Altimmune is operating at the current time. Most of Altimmune's value examination focuses on studying past and present price action to predict the probability of Altimmune's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Altimmune's price. Additionally, you may evaluate how the addition of Altimmune to your portfolios can decrease your overall portfolio volatility.